AIM ImmunoTech Inc. (AIM) Form 10-K Annual Reports
AIM ImmunoTech Inc. (AIM) is a publicly traded company on the NYSE, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AIM
CIK: 946644
Exchange: NYSE
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerRonaldo Totoli
Audit LocationMiami, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| ARS | 2026-09-30 | 2025-12-31 | ARS | 0001493152-26-045107 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-30 | 2026-09-30 | DEF 14A | 0001493152-26-045102 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | 4 | 0001493152-26-043246 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-16 | 4 | 0001493152-26-043073 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | 4 | 0001493152-26-042848 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-14 | 4 | 0001493152-26-042754 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-08 | 8-K | 0001493152-26-042592 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-03 | 8-K | 0001493152-26-042196 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-08-31 | 8-K | 0001493152-26-041537 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001493152-26-036996 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-07 | 8-K | 0001493152-26-036753 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001493152-26-036609 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-07-31 | 8-K | 0001493152-26-036408 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-07-31 | 8-K | 0001493152-26-036104 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-15 | 8-K | 0001493152-26-033514 | View SEC Doc Filr Page |
| S-8 | 2026-07-09 | — | S-8 | 0001493152-26-032678 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-25 | 2026-06-25 | DEF 14A | 0001493152-26-030043 | View SEC Doc Filr Page |
| 424B3 | 2026-06-24 | — | 424B3 | 0001493152-26-029934 | View SEC Doc Filr Page |
| EFFECT | 2026-06-23 | — | EFFECT Filing | 9999999995-26-002094 | View SEC Doc Filr Page |
| CORRESP | 2026-06-18 | — | CORRESP Filing | 0001493152-26-029405 | View SEC Doc Filr Page |
| UPLOAD | 2026-06-18 | — | UPLOAD Filing | 0000000000-26-006143 | View SEC Doc Filr Page |
| 424B3 | 2026-06-18 | — | 424B3 | 0001493152-26-029325 | View SEC Doc Filr Page |
| S-1 | 2026-06-18 | — | S-1 | 0001493152-26-029193 | View SEC Doc Filr Page |
| EFFECT | 2026-06-16 | — | EFFECT Filing | 9999999995-26-002022 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-15 | 2026-06-15 | PRE 14A | 0001493152-26-028732 | View SEC Doc Filr Page |